Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Brinda Adhikari, Tom Johnson, Maggie Bartlett, Dr. Mark Abdelmalek, Brinda Adhikari, Tom Johnson, Maggie Bartlett, and Dr. Mark Abdelmalek. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brinda Adhikari, Tom Johnson, Maggie Bartlett, Dr. Mark Abdelmalek, Brinda Adhikari, Tom Johnson, Maggie Bartlett, and Dr. Mark Abdelmalek or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How Do You Solve a Problem Like Big Pharma? We Ask a Bioethicist

1:11:19
 
Share
 

Manage episode 471187457 series 3645570
Content provided by Brinda Adhikari, Tom Johnson, Maggie Bartlett, Dr. Mark Abdelmalek, Brinda Adhikari, Tom Johnson, Maggie Bartlett, and Dr. Mark Abdelmalek. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brinda Adhikari, Tom Johnson, Maggie Bartlett, Dr. Mark Abdelmalek, Brinda Adhikari, Tom Johnson, Maggie Bartlett, and Dr. Mark Abdelmalek or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

"Big Pharma" — two words that Americans love to hate. When asked about the pharmaceutical industry, most of the country responds with a mix of anger and suspicion, using terms like "corporate capture," "revolving door," and "profits over people" to describe its influence, a sentiment felt even stronger after the pandemic. And yet, we are a nation that depends on their life-saving, life-improving products. Americans demand innovation from Big Pharma, but are simultaneously frustrated and mistrustful of their motives and influence. Today, we delve into our complex relationship with the pharmaceutical industry. What fuels this mistrust? Is there a better system? Joining us is bioethicist, author, and TED Talk star hailing from Penn State University Jonathan Marks, who believes it doesn’t have to be this way.

Hosts:

Brinda Adhikari

Tom Johnson

Maggie Bartlett

Dr. Mark Abdelmalek

Guest:

Jonathan Marks, Director of Bioethics Program at Penn State University, lawyer, author The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health

Sources:

2019 pharma ranked least well regarded industry

https://news.gallup.com/poll/266060/big-pharma-sinks-bottom-industry-rankings.aspx

2023 Gallup on pharma

https://news.gallup.com/poll/510641/retail-pharmaceutical-industries-slip-public-esteem.aspx

Lessons from Corporate Influence in the Opioid Epidemic https://pubmed.ncbi.nlm.nih.gov/32661741/

STAT on financial donations to Congress

https://www.statnews.com/feature/prescription-politics/federal-full-data-set/

NIH funds drug research

https://pmc.ncbi.nlm.nih.gov/articles/PMC5878010/

TED TALK: Jonathan Marks: In Praise of Conflict

https://www.youtube.com/watch?v=Sf8j5LFv3nI

Thanks for listening! If you like us, please leave a review, rate us, and please subscribe!
Got questions? Comments? We'd love to hear from you! Email us at [email protected]

  continue reading

Chapters

1. How Do You Solve a Problem Like Big Pharma? We Ask a Bioethicist (00:00:00)

2. Coming Up! (00:00:15)

3. Intro: Where Were You in March 2020? (00:01:35)

4. Big Pharma is a Red Hot Topic (00:04:55)

5. Profits Over People (00:06:21)

6. Where Else Can Researchers Go Besides Industry, If the Government is Closing Its Doors to Them? (00:22:30)

7. Marks: Taxpayers Are Paying At Both Ends (00:28:36)

8. Pharmaceutical Influence on Politicians (00:30:21)

9. Opioid Crisis and Revolving Door (00:32:56)

10. Marks: Influence Isn't Always Direct, It Can Be Tacit (00:35:25)

11. Direct to Consumer Advertising (00:37:57)

12. Broadening Our Understanding of Corruption (00:41:16)

13. Marks: We Have to Look At Regulation Differently (00:44:16)

14. An Alternative System (00:45:26)

15. Pharmaceutical Companies and Funding Drug Trials (00:48:32)

16. Vaccines Are Part of a System Leading to Distrust (00:54:26)

17. How To Promote Public Health and Promote Innovation? (00:57:11)

18. Did The Opioid Crisis Make Our Regulatory System Stronger Afterwards? (00:59:07)

19. Marks: Pharma's Good Actors Are Also Its Bad Actors (00:59:51)

20. Marks: Let's Create a System Which Creates Better Incentives (01:03:23)

21. How Should Doctors Communicate About Pharma? (01:06:00)

22. Put Forth a Positive Vision, Don't Just Defend Broken Status Quo (01:09:43)

23. Thank you! Please rate, review, like, subscribe! (01:11:04)

20 episodes

Artwork
iconShare
 
Manage episode 471187457 series 3645570
Content provided by Brinda Adhikari, Tom Johnson, Maggie Bartlett, Dr. Mark Abdelmalek, Brinda Adhikari, Tom Johnson, Maggie Bartlett, and Dr. Mark Abdelmalek. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brinda Adhikari, Tom Johnson, Maggie Bartlett, Dr. Mark Abdelmalek, Brinda Adhikari, Tom Johnson, Maggie Bartlett, and Dr. Mark Abdelmalek or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

"Big Pharma" — two words that Americans love to hate. When asked about the pharmaceutical industry, most of the country responds with a mix of anger and suspicion, using terms like "corporate capture," "revolving door," and "profits over people" to describe its influence, a sentiment felt even stronger after the pandemic. And yet, we are a nation that depends on their life-saving, life-improving products. Americans demand innovation from Big Pharma, but are simultaneously frustrated and mistrustful of their motives and influence. Today, we delve into our complex relationship with the pharmaceutical industry. What fuels this mistrust? Is there a better system? Joining us is bioethicist, author, and TED Talk star hailing from Penn State University Jonathan Marks, who believes it doesn’t have to be this way.

Hosts:

Brinda Adhikari

Tom Johnson

Maggie Bartlett

Dr. Mark Abdelmalek

Guest:

Jonathan Marks, Director of Bioethics Program at Penn State University, lawyer, author The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health

Sources:

2019 pharma ranked least well regarded industry

https://news.gallup.com/poll/266060/big-pharma-sinks-bottom-industry-rankings.aspx

2023 Gallup on pharma

https://news.gallup.com/poll/510641/retail-pharmaceutical-industries-slip-public-esteem.aspx

Lessons from Corporate Influence in the Opioid Epidemic https://pubmed.ncbi.nlm.nih.gov/32661741/

STAT on financial donations to Congress

https://www.statnews.com/feature/prescription-politics/federal-full-data-set/

NIH funds drug research

https://pmc.ncbi.nlm.nih.gov/articles/PMC5878010/

TED TALK: Jonathan Marks: In Praise of Conflict

https://www.youtube.com/watch?v=Sf8j5LFv3nI

Thanks for listening! If you like us, please leave a review, rate us, and please subscribe!
Got questions? Comments? We'd love to hear from you! Email us at [email protected]

  continue reading

Chapters

1. How Do You Solve a Problem Like Big Pharma? We Ask a Bioethicist (00:00:00)

2. Coming Up! (00:00:15)

3. Intro: Where Were You in March 2020? (00:01:35)

4. Big Pharma is a Red Hot Topic (00:04:55)

5. Profits Over People (00:06:21)

6. Where Else Can Researchers Go Besides Industry, If the Government is Closing Its Doors to Them? (00:22:30)

7. Marks: Taxpayers Are Paying At Both Ends (00:28:36)

8. Pharmaceutical Influence on Politicians (00:30:21)

9. Opioid Crisis and Revolving Door (00:32:56)

10. Marks: Influence Isn't Always Direct, It Can Be Tacit (00:35:25)

11. Direct to Consumer Advertising (00:37:57)

12. Broadening Our Understanding of Corruption (00:41:16)

13. Marks: We Have to Look At Regulation Differently (00:44:16)

14. An Alternative System (00:45:26)

15. Pharmaceutical Companies and Funding Drug Trials (00:48:32)

16. Vaccines Are Part of a System Leading to Distrust (00:54:26)

17. How To Promote Public Health and Promote Innovation? (00:57:11)

18. Did The Opioid Crisis Make Our Regulatory System Stronger Afterwards? (00:59:07)

19. Marks: Pharma's Good Actors Are Also Its Bad Actors (00:59:51)

20. Marks: Let's Create a System Which Creates Better Incentives (01:03:23)

21. How Should Doctors Communicate About Pharma? (01:06:00)

22. Put Forth a Positive Vision, Don't Just Defend Broken Status Quo (01:09:43)

23. Thank you! Please rate, review, like, subscribe! (01:11:04)

20 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play